articles
Press Releases
Results for the 3rd quarter 2018
- RESULTS OF THE CALL FOR EUROPEAN PROJECTS FET-OPEN - A NEW RESEARCH PROJECT WITH THE UNIVERSITY OF MONTPELLIERWe have received the answer from the European Commission: unfortunately, it is negative. However, we get a very good grade, and the comments of the...
read more
A joint experiment between CC&C and the IBDM
- Mechanical Signals and Cancer: a new experiment on colon cancer. First results expected early 2019. Based in Marseille, the IBDM brings together about twenty research teams that explore the field of developmental biology and associated pathologies, with daily...
read more
Results for the second quarter 2018
- EUROPEAN GRANT APPLICATION FET OPEN: 1.8 MILLION EURO REQUESTED, RESPONSE ON OCTOBER 16TH, 2018 - AFTER STANFORD UNIVERSITY, NEW PARTNERSHIPS IN PERSPECTIVE On May 16th, we submitted an application for a grant of 1.8 million Euro from the European Commission as part...
read more
Results for the first quarter 2018
- WITH THE SUPPORT OF INSERM, GET EUROPEAN FUNDS - LAST FUNDRAISE BEFORE CHANGING OUR FUNDING MODEL The FET-Open call for projects, which is part of the Horizon 2020 program for research initiated by the European Commission, selects its laureates for...
read more
Pancreatic Cancer: a decisive partnership with Stanford University by 2018
French start-up Cell Constraint & Cancer joins forces with one of the largest American Universities to find new therapeutic solutions for pancreatic cancer. "Year 2018 marks a turning point in the life of our company. Obtaining our Proof of Effeciency on...
read more
CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles
articles
Press Releases
Results for the 3rd quarter 2018
- RESULTS OF THE CALL FOR EUROPEAN PROJECTS FET-OPEN - A NEW RESEARCH PROJECT WITH THE UNIVERSITY OF MONTPELLIERWe have received the answer from the European Commission: unfortunately, it is negative. However, we get a very good grade, and the comments of the...
read more
A joint experiment between CC&C and the IBDM
- Mechanical Signals and Cancer: a new experiment on colon cancer. First results expected early 2019. Based in Marseille, the IBDM brings together about twenty research teams that explore the field of developmental biology and associated pathologies, with daily...
read more
Results for the second quarter 2018
- EUROPEAN GRANT APPLICATION FET OPEN: 1.8 MILLION EURO REQUESTED, RESPONSE ON OCTOBER 16TH, 2018 - AFTER STANFORD UNIVERSITY, NEW PARTNERSHIPS IN PERSPECTIVE On May 16th, we submitted an application for a grant of 1.8 million Euro from the European Commission as part...
read more
Results for the first quarter 2018
- WITH THE SUPPORT OF INSERM, GET EUROPEAN FUNDS - LAST FUNDRAISE BEFORE CHANGING OUR FUNDING MODEL The FET-Open call for projects, which is part of the Horizon 2020 program for research initiated by the European Commission, selects its laureates for...
read more
Pancreatic Cancer: a decisive partnership with Stanford University by 2018
French start-up Cell Constraint & Cancer joins forces with one of the largest American Universities to find new therapeutic solutions for pancreatic cancer. "Year 2018 marks a turning point in the life of our company. Obtaining our Proof of Effeciency on...
read more
CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles